REFERENCES
- Badalament RA, Hermansen DK, Kimmel M, Gay H, Herr HW, Fair WR, et al. The sensitivity of bladder wash flow cytometry, bladder wash cytology and voided cytology in the detection of bladder carcinoma. Cancer 1987; 60: 1423–8.
- Zein T, Wajsman Z, Englander LS, Gamarra M, Lopez C, Huben RP, Pontes JE. Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa. J Urol 1984; 132: 670–1.
- Soloway MS, Briggman iv, Carpinito GA, Chodak GW, Church PA, Lamm DL, et al. Use of a new tumor marker, urinary NMP22 in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol 1996; 156: 363–7.
- Irani J, Desgrandchamps F, Millet C, Toubert M, Bon D, Aubert J, Le Duc A. BTA stat and BTA TRAK: a comparative evaluation of urine testing for the diagnosis of transitional cell carcinoma of the bladder. Eur Urol 1999; 35: 89–92.
- Berezney R, Coffey DS. Identification of a nuclear protein matrix. Biochem Biophys Res Commun 1974; 60: 1410–5.
- Sarosdy MF, Hudson MA, Ellis WJ, Soloway MS, de Vere White R, Sheinfeld J, et al. Improved detection of recurrent bladder cancer using Bard BTA stat test. Urology 1997; 50: 349–53.
- Pode D, Shapiro A, Wald M, Nativ O, Laufer M, Kaver I. Noninvasive detection of bladder cancer with the BTA stat test. J Urol 1999; 161: 443–6.
- Ramakumar S, Bhuiyan J, Besse JA, Roberts SG, Wollan PC, Blute ML, O'Kane DJ. Comparison of screening methods in the detection of bladder cancer. J Urol 1999; 161: 388–94.
- Oge O, Erdem E, Atsfi N, Sahin A, Ozen H. Proposal for changes in cystoscopic follow-up of patients with low grade pTa bladder tumor. Eur Urol 2000; 37: 271–4.